Eric B. Haura
Impact in
- Oncology top 0.5%
- Cytokine Signaling Pathways and Interactions
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Cancer Cells and Metastasis
- Pulmonary and Respiratory Medicine top 0.2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 71
- Lung Cancer Diagnosis and Treatment 7
- Oncology 41
- Cytokine Signaling Pathways and Interactions 11
- Lung Cancer Research Studies 11
- Cancer Immunotherapy and Biomarkers 5
- Cancer-related Molecular Pathways 5
- Co-authors
- Lanxi Song (19 shared papers)Richard Jove (7 shared papers)James Turkson (5 shared papers)Domenico Coppola (15 shared papers)Gerold Bepler (26 shared papers)William Douglas Cress (23 shared papers)Srikumar Chellappan (9 shared papers)John M. Koomen (52 shared papers)
- Journals
- Journal of Thoracic Oncology (20 papers)Clinical Cancer Research (17 papers)Cancer Research (10 papers)Oncotarget (9 papers)PLoS ONE (8 papers)
- Partner nations
- United StatesAustriaSouth Korea
In The Last Decade
Eric B. Haura
256 papers receiving 18.6k citations
Eric B. Haura's Hit Papers
Peers
Comparison fields: 5 of 152
- Oncology 3.4k
- Pulmonary and Respiratory Medicine 4.0k
- Cancer Research 938
- Molecular Biology 2.4k
- Immunology 450
Countries citing papers authored by Eric B. Haura
This map shows the geographic impact of Eric B. Haura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric B. Haura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric B. Haura more than expected).
Fields of papers citing papers by Eric B. Haura
This network shows the impact of papers produced by Eric B. Haura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric B. Haura. The network helps show where Eric B. Haura may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric B. Haura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 262 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs Hit paper breakdown → | 2014 | 1434 |
| 2 | Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis Hit paper breakdown → | 2002 | 1053 |
| 3 | Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study Hit paper breakdown → | 2017 | 611 |
| 4 | Src kinases as therapeutic targets for cancer Hit paper breakdown → | 2009 | 600 |
| 5 | Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes Hit paper breakdown → | 2017 | 514 |
| 6 | Amivantamab in EGFR Exon 20 Insertion–Mutated Non–Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study Hit paper breakdown → | 2021 | 508 |
| 7 | 2007 | 403 | |
| 8 | Mutations in the DDR2 Kinase Gene Identify a Novel Therapeutic Target in Squamous Cell Lung Cancer Hit paper breakdown → | 2011 | 400 |
| 9 | 2001 | 387 | |
| 10 | 2005 | 375 | |
| 11 | Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial Hit paper breakdown → | 2021 | 343 |
| 12 | 2005 | 334 | |
| 13 | 2008 | 333 | |
| 14 | 2003 | 322 | |
| 15 | 2015 | 299 | |
| 16 | 2016 | 287 | |
| 17 | 2006 | 263 | |
| 18 | 2010 | 242 | |
| 19 | 2004 | 224 | |
| 20 | 2012 | 223 |
About Eric B. Haura
Eric B. Haura is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Spectroscopy, Molecular Biology and Cancer Research, having authored 262 papers that have together received 19.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (71 papers), Advanced Proteomics Techniques and Applications (18 papers), Cytokine Signaling Pathways and Interactions (11 papers), Lung Cancer Research Studies (11 papers), Lung Cancer Diagnosis and Treatment (7 papers), Smoking Behavior and Cessation (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Oncology (3.4k citations), Pulmonary and Respiratory Medicine (4.0k citations), Cancer Research (938 citations), Molecular Biology (2.4k citations) and Immunology (450 citations). Eric B. Haura has collaborated with scholars based in United States, Austria and South Korea. Frequent co-authors include Lanxi Song, Richard Jove, James Turkson, Domenico Coppola, Gerold Bepler, William Douglas Cress, Srikumar Chellappan, John M. Koomen, Zhong Zheng and Jiannong Li. Their work appears in journals such as Journal of Thoracic Oncology, Clinical Cancer Research, Cancer Research, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.